An international review of 54 randomized controlled trials found "very little evidence" that cannabis-based therapies effectively treat anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder, or opioid use disorders. The research, published in The Lancet Psychiatry, concluded that routine use of cannabinoids for mental health and substance use disorders is "rarely justified," despite growing legalization in countries including the US, UK, Australia, and Canada.
Otto Beta
1 comment
An international review of 54 randomized controlled trials found "very little evidence" that cannabis-based therapies effectively treat anxiety, anorexia nervosa, psychotic disorders, post-traumatic stress disorder, or opioid use disorders. The research, published in The Lancet Psychiatry, concluded that routine use of cannabinoids for mental health and substance use disorders is "rarely justified," despite growing legalization in countries including the US, UK, Australia, and Canada.